Tweenvest Stocks

Revium Rx. (OTCPK: RVRC)

Health Care · Biotechnology · IL

$1.43

today · -4.7% 1Y

Revium Rx. (OTCPK: RVRC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $86.84M and employs 1 people.

Over the last twelve months the share price has lost 4.7%, trading between 1.05 and 1.67.

Tweenvest scores Revium Rx. across four factors: quality 28/100. Its strongest factor is quality.

RVRC price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$86.84M
Revenue (TTM)
P/E
EPS
-0.22
Dividend yield
Beta (5Y)
-0.76
52-week high
$1.67
52-week low
$1.05
Avg volume (3M)
Shares outstanding
60.73M
Employees
1
Next earnings

About Revium Rx.

Operating from its Irvine, California headquarters, Revium Recovery Inc. is a United States-based entity engaged in the production and commercialization of an extensive portfolio of both alcoholic and non-alcoholic drinks. Its product catalog features a variety of specialized waters (structured and flavored), a selection of sports and energy beverages, green tea, and a range of spirits. The company also holds a significant strategic collaboration with Quantum TecH20. This enterprise, initially named OC Beverages, Inc., rebranded to Revium Recovery Inc. in December of 2020.

ISIN
US76151C1009
Founded
1997
Listed since
Jul 26, 2010
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
AbbVie Inc.NYSE: ABBV$468.22B$265.43+0.18%
Amgen Inc.NasdaqGS: AMGN$237.52B$440.98+0.38%
Gilead Sciences, Inc.NasdaqGS: GILD$181.18B$146.44+0.22%
Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX$138.91B$548.78+0.13%
Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN$83.28B$825.89-0.98%
argenx SEENXTBR: ARGX$65.85B864.20-4.19%
Moderna, Inc.NasdaqGS: MRNA$57.92B$139.44-3.88%
CSL LimitedASX: CSL$57.77BAU$168.30-1.69%

Browse every Biotechnology company →

Figures last refreshed Aug 18, 2026.